Effects of Montelukast on Airway Regulatory T Cells in Asthma
Status:
Unknown status
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
Montelukast is one of anti-inflammatory agents and a good controller for the patients with
asthma. The hypothesis of the study is that the Montelukast will have airway
anti-inflammatory effects and up-regulated regulatory T cells functions in asthma.